
Inflation and the Fed, Trump's Tariff Threats and Economic Team Picks, A Downer for Dell 11/27/24
Squawk on the Street
GLP-1 Drug Market Insights
This chapter explores the latest trends in the GLP-1 drug landscape, emphasizing Amgen's experimental obesity treatment and its competitive edge over established players. It also discusses market dynamics, regulatory proposals, and the broader health implications of obesity treatment.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.